IShares US Correlations
IHI Etf | USD 58.51 1.08 1.88% |
The correlation of IShares US is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IShares US moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IShares US Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Significant diversification
The correlation between IShares US Medical and NYA is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IShares US Medical and NYA in the same portfolio, assuming nothing else is changed.
IShares |
The ability to find closely correlated positions to IShares US could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IShares US when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IShares US - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IShares US Medical to buy it.
Moving together with IShares Etf
0.94 | XLV | Health Care Select | PairCorr |
0.94 | VHT | Vanguard Health Care | PairCorr |
0.66 | XBI | SPDR SP Biotech | PairCorr |
0.92 | IXJ | IShares Global Healthcare | PairCorr |
0.94 | IYH | IShares US Healthcare | PairCorr |
0.92 | FHLC | Fidelity MSCI Health | PairCorr |
0.91 | PULS | PGIM Ultra Short | PairCorr |
0.84 | MPAY | Akros Monthly Payout | PairCorr |
0.92 | BUFF | Innovator Laddered | PairCorr |
0.91 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
Moving against IShares Etf
0.75 | BITI | ProShares Trust - | PairCorr |
0.62 | GREI | Goldman Sachs Future | PairCorr |
0.43 | ARKG | ARK Genomic Revolution | PairCorr |
0.83 | BA | Boeing Fiscal Quarter End 31st of March 2024 | PairCorr |
0.74 | INTC | Intel Aggressive Push | PairCorr |
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Be your own money manager
Our tools can tell you how much better you can do entering a position in IShares US without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Already Invested in IShares US Medical?
The danger of trading IShares US Medical is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of IShares US is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than IShares US. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile IShares US Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether IShares US Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares US's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Us Medical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Us Medical Etf: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IShares US Medical. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the IShares US Medical information on this page should be used as a complementary analysis to other IShares US's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for IShares Etf analysis
When running IShares US's price analysis, check to measure IShares US's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IShares US is operating at the current time. Most of IShares US's value examination focuses on studying past and present price action to predict the probability of IShares US's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IShares US's price. Additionally, you may evaluate how the addition of IShares US to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
The market value of IShares US Medical is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares US's value that differs from its market value or its book value, called intrinsic value, which is IShares US's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares US's market value can be influenced by many factors that don't directly affect IShares US's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares US's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares US is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares US's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.